Pivotal bioVenture Partners Investment Advisor as of Dec. 31, 2023
Portfolio Holdings for Pivotal bioVenture Partners Investment Advisor
Pivotal bioVenture Partners Investment Advisor holds 13 positions in its portfolio as reported in the December 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Karuna Therapeutics Ord | 64.0 | $252M | 797k | 316.51 | |
Vaxcyte (PCVX) | 12.6 | $50M | 793k | 62.80 | |
Oculis Holding Ordinary Shares (OCS) | 5.4 | $21M | 1.9M | 11.23 | |
Inozyme Pharma (INZY) | 4.9 | $19M | 4.5M | 4.26 | |
Fusion Pharmaceuticals | 3.8 | $15M | 1.6M | 9.61 | |
Gracell Biotechnologies Sponsored Ads | 3.5 | $14M | 1.4M | 10.04 | |
Arcutis Biotherapeutics (ARQT) | 1.6 | $6.2M | 1.9M | 3.23 | |
Rallybio Corp (RLYB) | 1.5 | $5.7M | 2.4M | 2.39 | |
Exscientia Ads (EXAI) | 1.3 | $4.9M | 771k | 6.41 | |
Bolt Biotherapeutics (BOLT) | 0.5 | $2.1M | 1.9M | 1.12 | |
Vigil Neuroscience (VIGL) | 0.5 | $1.9M | 561k | 3.38 | |
Io Biotech (IOBT) | 0.4 | $1.6M | 864k | 1.88 | |
Aligos Therapeutics (ALGS) | 0.1 | $494k | 743k | 0.66 |